Telegraph.co.uk |
First-Line Abiraterone-ADT Combo for Hormone-Naïve PCa Ups Survival
Renal and Urology News CHICAGO—Adding abiraterone to androgen-deprivation therapy (ADT) as first-line treatment for advanced or high-risk prostate cancer (PCa) improves survival and delays disease progression compared with ADT alone, according to the findings of separate ... Cutting Chemo Time in Low-Risk Colon Ca an Option Prostate cancer major breakthrough - drug trial brings hope for men 'worldwide' Much shorter chemo works for many colon cancer patients, study says |
from Health - Google News http://ift.tt/2rW3SIS
EmoticonEmoticon